PCI Pharma Services is a United States-based company operating in the manufacturing sector, specifically within the pharmaceutical industry. Founded in 2012, the company employs between 1,001 and 5,000 individuals and reported significant revenue of approximately $1.45 billion. PCI Pharma Services specializes in high potency manufacturing, addressing the challenges associated with scalability in this rapidly growing segment of the pharmaceutical market. The company emphasizes the importance of reducing risk and ensuring consistent quality during the production of drug products containing high potency active pharmaceutical ingredients (HPAPIs). Their operational strategy includes flexible facility design to accommodate both small- and large-scale production, catering to various stages of drug development from early projects to commercialization. PCI Pharma Services also offers expertise in regulatory compliance, which is crucial for navigating the complexities of the pharmaceutical landscape. Their experienced staff provides a broad range of support, extending beyond manufacturing to include research and development, process optimization, and validation services.